{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:20:54Z","timestamp":1771273254183,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejphar.2016.06.014","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T16:00:41Z","timestamp":1465660841000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa"],"prefix":"10.1016","volume":"788","author":[{"given":"Anna","family":"Trzeciecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Jussi","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Toropainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Podracka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveliina","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Kauppinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Smedowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejphar.2016.06.014_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","article-title":"Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells","volume":"27","author":"Ammar","year":"2010","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.sjopt.2011.08.004","article-title":"Antiglaucoma drugs: the role of preservative-free formulations","volume":"25","author":"Bagnis","year":"2011","journal-title":"Saudi J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.014_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9394(00)00843-6","article-title":"Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics","volume":"131","author":"Brubaker","year":"2001","journal-title":"Am. J. Ophthalmol."},{"issue":"27","key":"10.1016\/j.ejphar.2016.06.014_bib4","doi-asserted-by":"crossref","first-page":"16979","DOI":"10.1074\/jbc.M115.646992","article-title":"Palmitoleate reverses high fat-induced proinflammatory macrophage polarization via AMP-activated protein kinase (AMPK)","volume":"290","author":"Chan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2016.06.014_bib5","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ophtha.2004.02.006","article-title":"Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma","volume":"111","author":"Christiansen","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.014_bib6","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/IOP.0b013e318201d32f","article-title":"Topical antiglaucoma treatment with prostaglandin analogues may precipitate meibomian gland disease","volume":"27","author":"Cunniffe","year":"2011","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.014_bib8","first-page":"619","article-title":"Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells","volume":"40","author":"De Saint Jean","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.014_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0271-3683(200002)2021-DFT085","article-title":"Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells","volume":"20","author":"De Saint Jean","year":"2000","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.014_bib10","first-page":"642","article-title":"Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2016.06.014_bib11","first-page":"447","article-title":"Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis","volume":"3","author":"Eyawo","year":"2009","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.014_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ejphar.2016.06.014_bib13","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.2337\/db08-1475","article-title":"Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice","volume":"58","author":"Fujisaka","year":"2009","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ejphar.2016.06.014_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1442-9071.2012.02781.x","article-title":"Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication","volume":"40","author":"Ghosh","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.014_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02169786","article-title":"Influence of artificial tears on corneal epithelium in dry-eye syndrome","volume":"227","author":"Gobbels","year":"1989","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.014_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI109412","article-title":"Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives","volume":"63","author":"Goetzl","year":"1979","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.ejphar.2016.06.014_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00417-003-0777-7","article-title":"In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells","volume":"241","author":"Hamard","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.014_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ICO.0b013e318265682c","article-title":"Morphologic alterations of the palpebral conjunctival epithelium in a dry eye model","volume":"32","author":"Henriksson","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ejphar.2016.06.014_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1358\/dot.2010.46.6.1482107","article-title":"A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension","volume":"46","author":"Hommer","year":"2010","journal-title":"Drugs Today"},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.014_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.2006.22.267","article-title":"Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study","volume":"22","author":"Labbe","year":"2006","journal-title":"J. Ocul. Pharm. Ther."},{"key":"10.1016\/j.ejphar.2016.06.014_bib23","first-page":"785","article-title":"Patient satisfaction with glaucoma therapy: reality or myth?","volume":"9","author":"Lemij","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.014_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.014_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2007.07.002","article-title":"Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study","volume":"115","author":"Lim","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.014_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.014_bib28","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1111\/aos.12131","article-title":"Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study","volume":"91","author":"Mastropasqua","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"8","key":"10.1016\/j.ejphar.2016.06.014_bib29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/DAD.0b013e31820e6210","article-title":"Immunohistochemical differences between normal and chronically inflamed conjunctiva: diagnostic features","volume":"33","author":"Mehta","year":"2011","journal-title":"Am. J. Derm."},{"key":"10.1016\/j.ejphar.2016.06.014_bib30","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1038\/srep13092","article-title":"Stearic acid induces proinflammatory cytokine production partly through activation of lactate-HIF1alpha pathway in chondrocytes","volume":"5","author":"Miao","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.014_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/112067210301300608","article-title":"Impression cytology of the conjunctival epithelium after antiglaucomatous treatment with latanoprost","volume":"13","author":"Moreno","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2016.06.014_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":"Vision related quality of life and topical glaucoma treatment side effects","volume":"1","author":"Nordmann","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ejphar.2016.06.014_bib33","first-page":"1189","article-title":"The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells","volume":"18","author":"Paimela","year":"2012","journal-title":"Mol. Vis."},{"issue":"13","key":"10.1016\/j.ejphar.2016.06.014_bib34","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1167\/iovs.12-10766","article-title":"In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation","volume":"53","author":"Pauly","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.014_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713683.2011.626909","article-title":"The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo","volume":"37","author":"Pellinen","year":"2012","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.ejphar.2016.06.014_bib37","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/OPX.0000000000000542","article-title":"Ocular Surface disease in glaucoma: effect of polypharmacy and preservatives","volume":"92","author":"Ramli","year":"2015","journal-title":"Optom. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.014_bib38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1590\/S0004-27492007000600005","article-title":"Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study","volume":"70","author":"Russ","year":"2007","journal-title":"Arq. Bras. Oftalmol."},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.014_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00125-013-2867-3","article-title":"Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism","volume":"56","author":"Salvado","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.014_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: relative value and place in therapy of available drug treatments","volume":"5","author":"Sambhara","year":"2014","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.ejphar.2016.06.014_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2415-11-14","article-title":"Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical\/pharmacy claims databases","volume":"11","author":"Schwartz","year":"2011","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib43","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J. Biochem. Pharm. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2016.06.014_bib44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/OPX.0000000000000664","article-title":"Altered mucin and glycoprotein expression in dry eye disease","volume":"92","author":"Stephens","year":"2015","journal-title":"Optom. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.014_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/10807680260362687","article-title":"Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study","volume":"18","author":"Taylor","year":"2002","journal-title":"J. Ocul. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.014_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.014_bib47","doi-asserted-by":"crossref","first-page":"e94102","DOI":"10.1371\/journal.pone.0094102","article-title":"Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation","volume":"9","author":"Wallner","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2016.06.014_bib48","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0039-6257(02)00306-5","article-title":"Effects of prostaglandins on the aqueous humor outflow pathways","volume":"47","author":"Weinreb","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ejphar.2016.06.014_bib49","doi-asserted-by":"crossref","first-page":"e45990","DOI":"10.1371\/journal.pone.0045990","article-title":"Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK\/SIRT1 pathway","volume":"7","author":"Xue","year":"2012","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T12:46:34Z","timestamp":1568033194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916303727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":46,"alternative-id":["S0014299916303727"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.014","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}